Two different estrogen receptors (ER-alpha and ER-beta) have been described, which are differentially involved in regulating the normal function of reproductive tissues. ER-alpha was considered for a long time to be the only estrogen receptor, and it has been detected in the stromal cells of the human prostate but not in the epithelium. To obtain new information about the differential effects of both receptor types, we have investigated their localization in normal prostates, benign prostatic hyperplasia (BPH), and prostatic cancer (PC) by immunohistochemistry, ELISA and Western blot. Epithelial immunostaining was absent in normal prostates and was present in BPH (10% of cells) and PC (80% of cells), whereas about 15% of stromal cells were positively immunostained for ER-alpha in the three types of prostatic specimens studied. Epithelial immunostaining for ER-beta was detected in normal prostates (13% of cells), BPH (30% of cells) and PC (79% of cells), whereas stromal immunostaining for ER-beta was absent in normal and hyperplastic prostates and was present in PC (12% of cells). The complementary presence of both receptor types in the normal prostate (ER-beta in the epithelium and ER-alpha in the stroma) might explain the mechanism of estrogen action in the development of BPH. The increased epithelial immunostaining for both ER-alpha and ER-beta in BPH and PC suggests that the involvement of estrogen receptors in hyperplasia and cancer concerns mainly the epithelium.

This article has been cited by other articles:

				C. K M Ho, J. Nanda, K. E Chapman, and F. K Habib Oestrogen and benign prostatic hyperplasia: effects on stromal cell proliferation and local formation from androgen J. Endocrinol., June 1, 2008; 197(3): 483 - 491. [Abstract] [Full Text] [PDF]

				K. T Gray, J. L Short, E. R Simpson, and S. Ventura The effects of targeted deletion of the aromatase enzyme on prostatic contractile responses to noradrenaline in mice J. Endocrinol., December 1, 2007; 195(3): 495 - 502. [Abstract] [Full Text] [PDF]

				J. Kindblom, K. Dillner, L. Sahlin, F. Robertson, C. Ormandy, J. Tornell, and H. Wennbo Prostate Hyperplasia in a Transgenic Mouse with Prostate-Specific Expression of Prolactin Endocrinology, June 1, 2003; 144(6): 2269 - 2278. [Abstract] [Full Text] [PDF]

				T. Tsurusaki, D. Aoki, H. Kanetake, S. Inoue, M. Muramatsu, Y. Hishikawa, and T. Koji Zone-Dependent Expression of Estrogen Receptors {alpha} and {beta} in Human Benign Prostatic Hyperplasia J. Clin. Endocrinol. Metab., March 1, 2003; 88(3): 1333 - 1340. [Abstract] [Full Text] [PDF]

				J. J. Bianco, D. J. Handelsman, J. S. Pedersen, and G. P. Risbridger Direct Response of the Murine Prostate Gland and Seminal Vesicles to Estradiol Endocrinology, December 1, 2002; 143(12): 4922 - 4933. [Abstract] [Full Text] [PDF]

				Z. Weihua, R. Lathe, M. Warner, and J.-A. Gustafsson An endocrine pathway in the prostate, ERbeta , AR, 5alpha -androstane-3beta ,17beta -diol, and CYP7B1, regulates prostate growth PNAS, October 15, 2002; 99(21): 13589 - 13594. [Abstract] [Full Text] [PDF]

				E. Holter, N. Kotaja, S. Makela, L. Strauss, S. Kietz, O. A. Janne, J.-A. Gustafsson, J. J. Palvimo, and E. Treuter Inhibition of Androgen Receptor (AR) Function by the Reproductive Orphan Nuclear Receptor DAX-1 Mol. Endocrinol., March 1, 2002; 16(3): 515 - 528. [Abstract] [Full Text] [PDF]